中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月8日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2020, Vol. 27 Issue (35): 44-47    
  临床研究 本期目录 | 过刊浏览 | 高级检索 |
多种治疗手段在中、重度慢性阻塞性肺疾病合并焦虑或忧郁治疗中的应用及对比
冯旋1 乐亮2 倪虹艳3
1.江西省景德镇市第一人民医院呼吸内科 2.江西省景德镇市第一人民医院药剂科 3.江西省景德镇市第一人民医院内分泌科
Application and comparison of various treatment methods in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression
FENG Xuan1 LE Liang2 NI Hong-yan3
1.Department of Respiratory Medicine,Jingdezhen First People′s Hospital 2.Department of Pharmacy,Jingdezhen First People′s Hospital 3.Department of Endocrinology,Jingdezhen First People′s Hospital
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 对比不同治疗手段在中、重度慢性阻塞性肺疾病合并焦虑或忧郁患者中的应用效果。方法 选取2017年1月~2019年11月景德镇市第一人民医院收治的150例中、重度慢性阻塞性肺疾病合并焦虑或忧郁患者,采用随机数字表法将其分为三组,每组各50例。A组患者采用原发疾病药物+心理疏导治疗,B组患者采用原发疾病药物治疗+精神类药物辅助治疗,C组患者采用心理疏导+原发疾病药物治疗+精神类药物辅助治疗。比较三组患者的临床疗效,比较三组患者治疗前、治疗6个月后的焦虑忧郁程度和肺功能。结果 C组患者的临床总有效率(98.00%)高于A组(78.00%)和B组(82.00%),差异有统计学意义(P<0.05)。三组患者治疗前的汉密顿焦虑量表(HAMA)、汉密顿抑郁量表(HAMD)评分比较,差异无统计学意义(P>0.05);C组患者治疗后的HAMA评分为(8.03±1.51)分,HAMD评分为(9.17±2.03)分,低 于A组[(12.21±3.01)、(13.06±3.16)分]和B组[(11.62±2.26)、(11.21±2.54)分],差异有统计学意义(P<0.05)。三组患者治疗前的第1 秒用力呼气容积(FEV1)、FEV1 占预计值的比值(FEV1%)、FEV1 占用力肺活量的比值(FEV1/FVC)比较,差异无统计学意义(P>0.05);C组患者治疗后的FEV1为(2.21±0.65)L,FEV1%为(53.74±7.93),FEV1/FVC 为(58.55±6.64)%,高于A组[(1.78±0.38)L、(46.51±7.41)、(55.79±6.59)%]和B组[(1.89±0.49)L、(48.26±7.62)、(55.83±6.32)%],差异有统计学意义(P<0.05)。结论 中、重度慢性阻塞性肺疾病合并焦虑或忧郁患者采用心理疏导+原发疾病药物+精神类药物辅助治疗效果较佳,能改善焦虑忧郁程度和肺功能,提高治疗效果,利于促进患者疾病恢复。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
冯旋
乐亮
倪虹艳
关键词 慢性阻塞性肺疾病焦虑忧郁肺功能    
Abstract:Objective To compare the application effect of various treatment methods in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression.Methods From January 2017 to November 2019,150 patients with moderate or severe chronic obstructive pulmonary disease combined with anxiety or depression were selected from Jingdezhen First People′s Hospital.They were divided into three groups by random number table method,50 cases in each group.Group A was treated with primary disease drugs + psychological counseling,group B was treated with primary disease drugs + adjuvant therapy with psychotropic drugs,group C was treated with psychological counseling + primary disease drugs + adjuvant therapy with psychotropic drugs.The clinical effect,anxiety and depression degree,lung function before and 6 months after treatment were compared among the three groups.Results The total clinical effective rate of group C (98.00%) was higher than that of group A (78.00%) and group B and(82.00%),the difference was statistically significant (P<0.05).There were no significant differences in Hamilton anxiety scale (HAMA) score and Hamilton depression scale (HAMD) score among the three groups before treatment (P>0.05).The HAMA score and HAMD score of group C after treatment were (8.03±1.51) points and (9.17±2.03) points,respectively,which were lower than those of group A ([12.21±3.01],[13.06±3.16]points) and group B ([11.62±2.26],[11.21±2.54]points),with statistically significant differences (P<0.05).There were no significant differences among the three groups in the forced expiratory volume at 1 second(FEV1),the ratio of FEV1 to the expected value (FEV1%),the ratio of FEV1 to the forced vital capacity (FEV1/FVC) (P>0.05).After treatment,FEV1 in group C was (2.21±0.65) L,FEV1% was (53.74±7.93),and FEV1/FVC was (58.55±6.64)%,higher than those in group A ([1.78±0.38]L,[46.51±7.41],[55.79±6.59]%) and group B ([1.89±0.49]L,[48.26±7.62],[55.83±6.32]%),with statistically significant differences (P<0.05).Conclusion Psychological counseling + primary disease drugs + adjuvant therapy with psychotropic drugs are effective in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression,which can improve the degree of anxiety and depression and lung function,improve the treatment effect,and promote the recovery of patients′ disease.
Key wordsChronic obstructive pulmonary disease    Anxiety    Depression    Pulmonary function
    
基金资助:江西省景德镇市科技计划项目(20191SFZC022)
作者简介: 冯旋(1985-),男,江西景德镇人,本科,主治医师,研究方向:呼吸系统慢性疾病的优化诊治
引用本文:   
冯旋;乐亮;倪虹艳. 多种治疗手段在中、重度慢性阻塞性肺疾病合并焦虑或忧郁治疗中的应用及对比[J]. 中国当代医药, 2020, 27(35): 44-47.
FENG Xuan;LE Liang;NI Hong-yan. Application and comparison of various treatment methods in the treatment of moderate and severe chronic obstructive pulmonary disease with anxiety or depression. 中国当代医药, 2020, 27(35): 44-47.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2020/V27/I35/44
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载